Volume 21, Number 7—July 2015
CME ACTIVITY - Research
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
Table 1
Test | Specimens, no. (%) | Patients, no. (%) |
---|---|---|
Total no. | 420 (100) | 308 (100) |
PCR+ for HPeV | 289 (69) | 198 (64) |
PCR+ for HPeV only | 285 (68) | 194 (63) |
PCR+ for HPeV and EV† | 4 (1) | 4 (1) |
PCR+ for EV only | 15 (4) | 14 (5) |
PCR+ for EV | 19 (5) | 18 (6) |
PCR− for HPeV | 131 (31) | 110 (36) |
PCR− for HPeV and EV | 116 (28) | 96 (31) |
*EV, enterovirus; HPeV, human parechovirus;VIDRL, Victorian Infectious Disease Reference Laboratory: +, positive; –, negative.
†Because of how the testing algorithm is set up at VIDRL, all samples tested for HPeV are also tested for EV. EV results are shown to demonstrate the small amount of EV detected in this HPeV outbreak period, with even fewer co-infections.
1Current affiliation: Independent consultant, Freshwater, New South Wales, Australia
Page created: June 15, 2015
Page updated: June 15, 2015
Page reviewed: June 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.